Anne-Marie O’Farrell

A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R

Christi Parham, Madaline Chirica, Jacqueline Timans et al. · The Journal of Immunology · 2002 · 1.3K citations

Life Sciences, Immunology, Cell Signaling +8

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

Walter Fiedler, Hubert Serve, Hartmut Döhner et al. · Blood · 2005 · 492 citations

Medicine, Oncology, Pharmacology +13

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity

Shem Patyna, Alexander Laird, Dirk B. Mendel et al. · Molecular Cancer Therapeutics · 2006 · 103 citations

Medicine, Oncology, Pharmacology +17

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification

Samuel E. DePrimo, Lily Wong, Deepak Khatry et al. · BMC Cancer · 2003 · 98 citations · Full text

Medicine, Oncology, Pharmacology +17

Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia

Anne-Marie O’Farrell, Helene A. Yuen, Beverly D. Smolich et al. · Leukemia Research · 2004 · 76 citations

Medicine, Oncology, Pharmacology +14